China announced on Friday that it would raise its levies on imports of U.S. goods to 125%, hitting back at U.S. President ...

This FTSE 100 firm's smaller than rivals but could benefit from its big US manufacturing footprint and competitive market ...

In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...

UK-based drug companies AstraZeneca and GSK could be affected by Trump’s next decision, as Karl Matchett reports ...

Something seems to be going awry with GlaxoSmithKline's game plan for its respiratory franchise, with new products positioned ... is "on course to be one of our best launches." ...

The drug remains one of GSK's top products, with sales of £856 million ($1.1 billion) in the first half of this year, up 15%. COPD could open up a massive new market for the drug, which still has ...

The following organizations have been chosen as Canada’s Greenest Employers for 2025 (employee count refers to full-time ...

Pharmaceutical industry experts have suggested to The Independent that while total pharma exports from the UK to the US are “significant”, with up to a third of products ... GSK sits in the ...